## Core Concept
Sulfonylureas are a class of medications used to manage type 2 diabetes mellitus. They act by stimulating the release of insulin from the pancreatic beta cells. This mechanism is crucial for lowering blood glucose levels in diabetic patients.

## Why the Correct Answer is Right
The correct answer, . , indicates that sulfonylureas work by closing ATP-sensitive potassium channels in the pancreatic beta cells. This closure leads to cell depolarization, which opens voltage-gated calcium channels, resulting in an influx of calcium ions. The increased intracellular calcium concentration triggers the exocytosis of insulin-containing granules, thereby increasing insulin secretion. This action is dependent on the presence of functioning pancreatic beta cells.

## Why Each Wrong Option is Incorrect
* **Option A:** - This option is incorrect because sulfonylureas do not primarily act by inhibiting gluconeogenesis in the liver, although some may have a minor effect on this pathway. Their primary mechanism is related to insulin secretion.
* **Option B:** - This option is incorrect as sulfonylureas do not work by increasing insulin sensitivity; that is the mechanism of action for thiazolidinediones (TZDs) or glitazones.
* **Option D:** - This option is incorrect because sulfonylureas do not primarily act by delaying glucose absorption from the gut; that would be more related to the mechanism of alpha-glucosidase inhibitors.

## Clinical Pearl / High-Yield Fact
A key point to remember is that sulfonylureas can cause hypoglycemia as a side effect due to their insulin-stimulating action. This risk is higher with certain sulfonylureas like glyburide and glipizide.

## Correct Answer Line
**Correct Answer: C. **